4//SEC Filing
Dritschilo Anatoly 4
Accession 0001493152-23-000026
CIK 0001757499other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 6:20 AM ET
Size
6.6 KB
Accession
0001493152-23-000026
Insider Transaction Report
Form 4
Dritschilo Anatoly
DirectorCEO and Chairman10% Owner
Transactions
- Sale
COMMON STOCK
2022-12-29$1.60/sh−8,372$13,437→ 1,085,200 total
Holdings
- 3,204,407(indirect: By Spouse)
COMMON STOCK
Footnotes (3)
- [F1]Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 22,748 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.
- [F2]Consists of 1,085,200 shares of common stock held directly by the Reporting Person.
- [F3]Consists of 3,204,407 shares of common stock held by the Reporting Person's spouse, over which the Reporting Person disclaims any beneficial ownership or control. The inclusion in this report of the 3,204,407 shares held by the Reporting Person's spouse shall in no way be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Shuttle Pharmaceuticals Holdings, Inc.
CIK 0001757499
Entity typeother
Related Parties
1- filerCIK 0001945126
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 6:20 AM ET
- Size
- 6.6 KB